Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous dexamethasone and glycemic control after total knee arthroplasty in type 2 diabetes mellitus
KCT0006921Phase 4Not yet recruiting
- Sponsor
- SMG-SNU Boramae Medical Center
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in type 2 diabetes mellitus (T2DM) and osteoarthritis (OA) (2 arms), sponsored by SMG-SNU Boramae Medical Center. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
type 2 diabetes mellitus (T2DM)osteoarthritis (OA)
Beyond the preview
Go deeper on KCT0006921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006921.